炎症性肠病的疾病严重性指数是一个有效的工具,可以预测复杂的疾病
Akhilesh Swaminathan1,2, James M Fulforth3, Chris M Frampton1
1Department of Medicine, University of Otago, Christchurch, New Zealand.
Inflammatory bowel diseases
|December 22, 2023
概括
经过验证的炎症性肠病 (IBD) 疾病严重性指数 (DSI) 准确预测疾病进展和并发症. 这种工具结合了表型,炎症和患者的结果,以可靠地预测IBD过程.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 患者研究成果研究结果
背景情况:
- 炎症性肠病 (IBD) 管理需要全面的评估工具.
- 疾病严重性指数 (DSI) 整合了疾病表型,炎症活性和患者报告的结果.
- 对DSI的验证对于其在预测IBD过程中的临床实用性至关重要.
研究的目的:
- 在成年IBD患者的多中心队列中验证疾病严重性指数 (DSI).
- 评估DSI预测复杂IBD过程的能力.
- 评估DSI与已建立的疾病评估措施的相关性.
主要方法:
- 招募一个多中心成人IBD队列.
- 通过使用ICC和Kappa统计数据评估DSI评级者之间的可靠性.
- 对DSI与内镜指数,症状得分,生活质量和残疾措施的相关性分析.
- 用AUROC和后勤回归来确定复杂IBD课程的子组的前性跟踪.
主要成果:
- DSI证明了克罗恩病 (CD) 和性结肠炎 (UC) 之间的高度可靠性和内部一致性.
- 在DSI和内镜活动,症状,生活质量和残疾之间观察到显著的相关性.
- 23的DSI值有效预测了复杂的IBD过程 (AUROC = 0.82),具有显著的多变量关联 (aOR = 9.20).
结论:
- 疾病严重程度指数 (DSI) 是评估炎症性肠病严重程度的可靠工具.
- DSI准确预测IBD的纵向过程,包括并发症的风险.
- 经过验证的DSI可以帮助临床医生预测和管理IBD进展.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
9.4K
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
31.8K
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
251
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
251
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
188
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
188
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:17Chronic Bowel Disorders: Introduction
456
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
01:29Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121